Alexandra da Palma Guerreiro

MARCKS affects cell motility and response to BTK inhibitors in CLL.

M. Hallek, S. Stilgenbauer, A. Wiestner, 2021, Blood.

An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities.

A. Letai, C. Schmitt, L. Pasqualucci, 2020, Blood cancer discovery.

Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies

R. Herwig, M. Peifer, M. Hallek, 2022, Blood.